APO-DIPYRIDAMOLE TABLET

Quốc gia: Canada

Ngôn ngữ: Tiếng Anh

Nguồn: Health Canada

Thành phần hoạt chất:

DIPYRIDAMOLE

Sẵn có từ:

APOTEX INC

Mã ATC:

B01AC07

INN (Tên quốc tế):

DIPYRIDAMOLE

Liều dùng:

25MG

Dạng dược phẩm:

TABLET

Thành phần:

DIPYRIDAMOLE 25MG

Tuyến hành chính:

ORAL

Các đơn vị trong gói:

250ML

Loại thuốc theo toa:

Prescription

Khu trị liệu:

MISCELLANEOUS VASODILATATING AGENTS

Tóm tắt sản phẩm:

Active ingredient group (AIG) number: 0106621001; AHFS:

Tình trạng ủy quyền:

APPROVED

Ngày ủy quyền:

2021-08-12

Đặc tính sản phẩm

Page 1 of 18
PRODUCT MONOGRAPH
PR
APO-DIPYRIDAMOLE
DIPYRIDAMOLE TABLETS USP
25, 50, 75 AND 100 MG
PR
APO-DIPYRIDAMOLE-SC
DIPYRIDAMOLE SUGAR-COATED TABLETS USP
25, 50 AND 75 MG
CORONARY VASODILATOR
INHIBITOR OF PLATELET ADHESION AND AGGREGATION
APOTEX INC.
150 SIGNET DRIVE
TORONTO, ONTARIO
DATE OF REVISION:
M9L 1T9
AUGUST 10, 2021
CONTROL NUMBER: 246833
Page 2 of 18
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.....................................................................
3
SUMMARY PRODUCT
INFORMATION......................................................................................
3
INDICATIONS AND CLINICAL USES
.........................................................................................
3
CONTRAINDICATIONS
.............................................................................................................
3
WARNINGS AND PRECAUTIONS
.............................................................................................
3
ADVERSE
REACTIONS.............................................................................................................
4
DRUG INTERACTIONS
.............................................................................................................
5
DOSAGE AND ADMINISTRATION
.............................................................................................
6
OVERDOSAGE..........................................................................................................................
6
ACTION AND CLINICAL PHARMACOLOGY
..............................................................................
6
STORAGE AND STABILITY
.......................................................................................................
7
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................................. 7
PART II: SCIENTIFIC INFORMATION
...........................................................................................
9
PHARMACEUTICAL INFORMATION
.............................................